Femto Technologies Receives Patent Allowance for AI-Powered Femtech Device Sensera

Femto Technologies Inc. (Nasdaq: FMTO) has achieved a critical milestone with the U.S. Patent and Trademark Office granting a Notice of Allowance for its Sensera female treatment device design. This patent allowance solidifies the company's intellectual property protection for its innovative Femtech product, which recently earned recognition as a CES Innovation Awards® 2025 honoree in the AI category. The approval underscores the growing importance of patented technology in the competitive Femtech sector, where intellectual property rights can determine market leadership and commercial success.

The Sensera device incorporates Femto's proprietary Smart Release System technology, which utilizes machine learning and artificial intelligence to enhance feminine wellness. According to CEO Yftah Ben Yaackov, this technology represents the forefront of innovation in driving transformative advancements within the Femtech industry. The company's commitment to AI-driven solutions reflects the broader trend of integrating intelligent technology into wellness products, potentially setting new standards for efficacy and user experience in women's health technology.

This development carries significant implications for the Femtech market, as patent protection enables Femto Technologies to establish a competitive barrier against imitation while potentially attracting investment and partnership opportunities. The recognition from both the USPTO and CES validates the company's technological approach and may accelerate adoption among consumers seeking scientifically-backed wellness solutions. For more information about the Sensera device, visit https://www.senserawellness.com.

Femto's achievement also highlights the increasing regulatory and commercial validation of AI-powered health devices, particularly in the sensitive area of feminine wellness. The patent allowance process demonstrates the company's adherence to rigorous development standards and its ability to meet the USPTO's requirements for novelty and utility. This milestone may influence how other Femtech companies approach product development and intellectual property strategy, potentially raising industry standards for innovation and protection.

The company maintains its commitment to research and development, with ongoing initiatives focused on expanding applications of its SRS technology across various Femtech solutions. This patent success reinforces Femto's position in the rapidly evolving wellness technology landscape and demonstrates the growing acceptance of AI-driven approaches to addressing women's health needs. The combination of patent protection and industry recognition positions the company for potential market expansion and technological leadership in the specialized Femtech sector.